Type 2 diabetes mellitus Trials in Las Vegas, United States
Conditions / Type 2 diabetes mellitus / Las Vegas, United States
Type 2 diabetes mellitus is a medical condition with active clinical research programs worldwide.
59 total trials for this combination
Showing top 10 of 59 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04255433 | A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01144338 | Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT01031680 | Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension | COMPLETED | PHASE3 |
| NCT03496298 | Effect of Efpeglenatide on Cardiovascular Outcomes | TERMINATED | PHASE3 |
| NCT01789957 | Extension Study for 2993-112 | COMPLETED | PHASE3 |
| NCT00856284 | Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT05254002 | A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes | COMPLETED | PHASE2 |
| NCT01107886 | Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications | COMPLETED | PHASE4 |
| NCT03315143 | Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk | TERMINATED | PHASE3 |
| NCT02537470 | Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes | COMPLETED | PHASE2 |